Disease-Associated miRNA-mRNA Networks in Oral Lichen Planus

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Gassling, Volker ^a   Hampe, Jochen ^a   Açil, Yahya ^a   Braesen, Jan Hinrich ^a   Wiltfang, Jörg ^a   Häsler, Robert ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTIVE SURGERY; GENE IDENTIFICATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; INFLAMMATION; LICHEN PLANUS; MAJOR CLINICAL STUDY; MOUTH MUCOSA; ORAL SURGERY; PATHOPHYSIOLOGY; PRECANCER; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY RNA SEQUENCE; TISSUE SECTION; TRANSCRIPTION REGULATION; VALIDATION PROCESS;

CASE-CONTROL STUDIES; CLUSTER ANALYSIS; GENE EXPRESSION; GENE REGULATORY NETWORKS; HUMANS; LICHEN PLANUS, ORAL; MICRORNAS; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; RNA INTERFERENCE; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84878325971     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063015     Document Type: Article

References (52)

1. Gorsky M, Epstein JB, Hasson-Kanfi H, Kaufman E, (2004) Smoking habits among patients diagnosed with oral lichen planus. Tob Induc Dis 2: 103-108.
2. Eisenberg E, (2000) Oral lichen planus: a benign lesion. J Oral Maxillofac Surg 58: 1278-1285.
3. Silverman S Jr, (2000) Oral lichen planus: a potentially premalignant lesion. J Oral Maxillofac Surg 58: 1286-1288.
4. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I (1997) Definitions and Explanatory Notes. In: Histological typing of cancer and precancer of the oral mucosa. Springer, Berlin Heidelberg New York. 29 and 21.
5. Reichart PA, Philipsen HP, (2005) Oral erythroplakia - a review. Oral Oncol 41: 551-561.
6. Ha PK, Pilkington TA, Westra WH, Sciubba J, Sidransky D, et al. (2002) Progression of microsatellite instability from premalignant lesions to tumors of the head and neck. Int J Cancer 102: 615-617.
7. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
8. Kaatsch P, Spix C, Katalinic A, Hentschel St, Baras N, et al. (2008) Cancer in Germany 2007-2008 - Incidence and Trends. eigth edition.
9. Wu L, Fan J, Belasco JG, (2006) MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A 103: 4034-4039.
10. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
11. Chen CZ, (2005) MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771.
12. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
13. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
14. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
15. Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, et al. (2008) MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 123: 2791-2797.
16. Cervigne NK, Reis PP, Machado J, Sadikovic B, Bradley G, et al. (2009) Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 18: 4818-4829.
17. Krichevsky AM, Gabriely G, (2009) miR-21: a small multi-faceted RNA. J Cell Mol Med 13: 39-53.
18. Ha PK, Benoit NE, Yochem R, Sciubba J, Zahurak M, et al. (2003) A transcriptional progression model for head and neck cancer. Clin Cancer Res 9: 3058-3064.
19. van der Meij EH, Schepman KP, van der Waal I, (2003) The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96: 164-171.
20. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH, (1978) Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46: 518-539.
21. Mah N, Thelin A, Lu T, Nikolaus S, Kuhbacher T, et al. (2004) A comparison of oligonucleotide and cDNA-based microarray systems. Physiol Genomics 16: 361-370.
22. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
23. Westfall PH, Young S (1993) Resampling-Based Multiple Testing. New York: Wiley-Interscience.
24. Tavazoie S, Hughes JD, Campbell MJ, Cho RJ, Church GM, (1999) Systematic determination of genetic network architecture. Nat Genet 22: 281-285.
25. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E, (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284.
26. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, et al. (2011) miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 39: D163-D169.
27. Zhang L, Michelsen C, Cheng X, Zeng T, Priddy R, et al. (1997) Molecular analysis of oral lichen planus. A premalignant lesion? Am J Pathol 151: 323-327.
28. Liu X, Chen Z, Yu J, Xia J, Zhou X (2009) MicroRNA Profiling and Head and Neck Cancer. Comp Funct Genomics 837514.
29. Clague J, Lippman SM, Yang H, Hildebrandt MA, Ye Y, et al. (2010) Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Mol Carcinog 49: 183-189.
30. Grigoryev YA, Kurian SM, Hart T, Nakorchevsky AA, Chen C, et al. (2011) MicroRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytes. J Immunol 187: 2233-2243.
31. Huang JC, Babak T, Corson TW, Chua G, Khan S, et al. (2007) Using expression profiling data to identify human microRNA targets. Nat Methods 4: 1045-1049.
32. Lionetti M, Biasiolo M, Agnelli L, Todoerti K, Mosca L, et al. (2009) Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood 114: e20-e26.
33. Costello CM, Mah N, Hasler R, Rosenstiel P, Waetzig GH, et al. (2005) Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med 2: e199.
34. Hasler R, Kerick M, Mah N, Hultschig C, Richter G, et al. (2011) Alterations of pre-mRNA splicing in human inflammatory bowel disease. Eur J Cell Biol 90: 603-611.
35. Avissar M, Christensen BC, Kelsey KT, Marsit CJ, (2009) MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 15: 2850-2855.
36. Hasler R, Begun A, Freitag-Wolf S, Kerick M, Mah N, et al. (2009) Genetic control of global gene expression levels in the intestinal mucosa: a human twin study. Physiol Genomics 38: 73-79.
37. Ismail SB, Kumar SK, Zain RB, (2007) Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 49: 89-106.
38. Hasler R, Jacobs G, Till A, Grabe N, Cordes C, et al. (2012) Microbial pattern recognition causes distinct functional micro-RNA signatures in primary human monocytes. PLoS One 7: e31151.
39. Lee Y, Jeon K, Lee JT, Kim S, Kim VN, (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21: 4663-4670.
40. Lee Y, Kim M, Han J, Yeom KH, Lee S, et al. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23: 4051-4060.
41. Tauber S, Jais A, Jeitler M, Haider S, Husa J, et al. (2010) Transcriptome analysis of human cancer reveals a functional role of heme oxygenase-1 in tumor cell adhesion. Mol Cancer 9: 200.
42. Enarsson K, Johnsson E, Lindholm C, Lundgren A, Pan-Hammarstrom Q, et al. (2006) Differential mechanisms for T lymphocyte recruitment in normal and neoplastic human gastric mucosa. Clin Immunol 118: 24-34.
43. Lindstrom MS, Nister M, (2010) Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation. PLoS One 5: e9578.
44. Zhang Q, He J, Lu W, Yin W, Yang H, et al. (2010) [Expression of transient receptor potential canonical channel proteins in human non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi 13: 612-616.
45. Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I, et al. (2012) Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol 48: 686-691.
46. Yu T, Wang XY, Gong RG, Li A, Yang S, et al. (2009) The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res 28: 64.
47. Scapoli L, Palmieri A, Lo ML, Pezzetti F, Rubini C, et al. (2010) MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol 23: 1229-1234.
48. Park JK, Henry JC, Jiang J, Esau C, Gusev Y, et al. (2011) miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun 406: 518-523.
49. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, et al. (2008) Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 14: 2588-2592.
50. Lajer CB, Nielsen FC, Friis-Hansen L, Norrild B, Borup R, et al. (2011) Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer 104: 830-840 bjc201129 [pii];10.1038/bjc.2011.29 [doi].
51. Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW, et al. (2010) Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 16: 360-364.
52. Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY, et al. (2010) miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res 70: 1635-1644.